Lynn E. S̄pitler

7.3k citations
124 papers · 5.9k · 1 hit paper · h-index 32

Impact in

  • Immunology top 0.5%
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology
    • Immunodeficiency and Autoimmune Disorders
    • Toxin Mechanisms and Immunotoxins
  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • Cutaneous Melanoma Detection and Management

Papers in

    • Immunotherapy and Immune Responses 27
    • Immunodeficiency and Autoimmune Disorders 18
    • T-cell and B-cell Immunology 17
    • Toxin Mechanisms and Immunotoxins 12
    • Cutaneous Melanoma Detection and Management 27
    • Cancer Immunotherapy and Biomarkers 11

Lynn E. S̄pitler

120 papers receiving 5.2k citations

Lynn E. S̄pitler's Hit Papers

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma 2015 · 2.2k citations
2.2k0+3+7Years since publication5001k1.5k2k

Peers

Lynn E. S̄pitler
Comparison fields: 5 of 112
  • Immunology 2.1k
  • Oncology 1.6k
  • Genetics 980
  • Neurology 238
  • Pathology and Forensic Medicine 258
Replace James T. Casper with:
James T. Casper United States
Thomas A. Fleisher United States
L M Souza United States
Kazuo Tamura Japan
Claudia A. Müller Germany
Kajsa Wing Sweden
Kenneth Francis Bradstock Australia
William R. Drobyski United States
Yvette E Latchman United States
Michael B. Jordan United States
Lynn E. S̄pitler relative to James T. Casper United States James T. Casper's profile →
Citations per field
00.5×2×3×3.7×
James T. Casper · 1×
Citations per year

Countries citing papers authored by Lynn E. S̄pitler

Since Specialization
Citations

This map shows the geographic impact of Lynn E. S̄pitler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn E. S̄pitler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn E. S̄pitler more than expected).

Fields of papers citing papers by Lynn E. S̄pitler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn E. S̄pitler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn E. S̄pitler. The network helps show where Lynn E. S̄pitler may publish in the future.

Co-authors

The 25 scholars most cited alongside Lynn E. S̄pitler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lynn E. S̄pitler Line = papers co-authored together Lynn E. S̄pitler links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 124 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Hit paper breakdown →
20152166
2 1977334
3 2000228
4 1973203
5
Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin.
1987185
6 1972158
7 1970144
8 2000105
9 197585
10 197283
11 197079
12
Immunologic approaches to the treatment of prostate cancer.
199974
13 197571
14 197571
15 197465
16 201963
17 196962
18 197461
19 199160
20 197357

About Lynn E. S̄pitler

Lynn E. S̄pitler is a scholar working on Immunology, Oncology, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Epidemiology, having authored 124 papers that have together received 5.9k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (27 papers), Immunotherapy and Immune Responses (27 papers), Immunodeficiency and Autoimmune Disorders (18 papers), T-cell and B-cell Immunology (17 papers), Toxin Mechanisms and Immunotoxins (12 papers), Cancer Immunotherapy and Biomarkers (11 papers), Multiple Sclerosis Research Studies (8 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). The work is most often cited by research in Immunology (2.1k citations), Oncology (1.6k citations), Genetics (980 citations), Neurology (238 citations) and Pathology and Forensic Medicine (258 citations). Lynn E. S̄pitler has collaborated with scholars based in United States, United Kingdom and Austria. Frequent co-authors include H. Hugh Fudenberg, Alan S. Levin, Joseph Wybran, Peter C. Dau, Edward E. Shev, Jon Martin Lindstrom, Eric H. Denys, Christine K. Cassel, Antonino Catanzaro and Kenneth Μ. Moser. Their work appears in journals such as Cancer, Journal of Clinical Oncology, Cellular Immunology, The Journal of Immunology and Melanoma Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact